School personnel information

写真b

YAGI Kiyohito


Keyword

Biotechnology, Regenerative Medicine

Mail Address

Mail Address

Gender

Male

Organization 【 display / non-display

  • 2000.03.01 - 2012.03.31, Molecular Pharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Professor

  • 2012.04.01 - 2018.03.31, Advanced Pharmaco-science, Graduate School of Pharmaceutical Sciences, Professor

  • 2018.04.01 - , Graduate School of Pharmaceutical Sciences, Specially Appointed Professor

Education 【 display / non-display

Osaka University Faculty of Pharmaceutical Science  Graduated 1976.03
Osaka University Graduate School, Division of Pharmaceutical Sciences  Completed 1978.03
Osaka University Graduate School, Division of Pharmaceutical Sciences  Completed Ph.D. 1981.09

Employment Record 【 display / non-display

Assistant Professor, Osaka University 1983.04 - 1992.03
Associate Professor, Osaka University 1992.04 - 2000.02

Research topics 【 display / non-display

  • Hepatocyte Transplantation, Differentiation of Bone Marrow Cells to Hepatocytes, Development of Bioartificial Liver, Oral DDS using clay mineral, Whole cell biosensor
    Pharmaceutical hygiene and biochemistry-related

 

Academic Papers 【 display / non-display

  • Engineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5. , Yosuke Hashimoto, Wei Zhow, Kohtaroh Hamauchi, Keisuke Shirakura, Takefumi Doi, Kiyohito Yagi, Tatsuya Sawasaki, Yoshiaki Okada, Masuo Kondoh, Hiroyuki Takeda, Scientific Reports, Sci Rep, 2018, 8, 8383., 2018.05, Papers

  • Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system., Zeniya S, Kuwahara H, Daizo K, Watari A, Kondoh M, Yoshida-Tanaka K, Kaburagi H, Asada K, Nagata T, Nagahama M, Yagi K, Yokota T, Journal of Controlled Release, 2018.05, Papers

  • Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2., Yosuke Hashimoto,Tomoyuki Hata, Minoru Tada, Manami Iida, Akihiro Watari, Yoshiaki Okada, Takefumi Doi, Hiroki Kuniyasu, Kiyohito Yagi, Masuo Kondoh, European Journal of Pharmaceutical Sciences,117 161-167, 2018.05, Papers

  • Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model., Yoshimi Shimizu, Yoshitaka Shirasago, Masuo Kondoh, Tetsuro Suzuki, Takaji Wakita, Kentaro Hanada, Kiyohito Yagi, Masayoshi Fukasawa, Journal of Virology,J. Virol. April 2018 vol. 92 no. 8 e02258-17 , 2018.04, Papers

  • Lignosulfonic acid attenuates NF-kappa B activation and intestinal epithelial barrier dysfunction induced by TNF-alpha/IFN-gamma in Caco-2 cells, Matsuhisa Koji, Watari Akihiro, Iwamoto Kazuki, Kondoh Masuo, Yagi Kiyohito, JOURNAL OF NATURAL MEDICINES,72(2) 448-455, 2018.03, Papers

display all >>

Books 【 display / non-display

  • Other, What kind of train is PharmaTrain? Acually it is a human resource development program that contributes to drug development, Kiyohito Yagi, Manufacturing & Technology, 2019.05